跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,152 条关于
“dMMR tumors”
全部
24,152
临床试验
18,155
药物
476
机构
55
资讯
5,466
去年
Novartis' Oral WRN Helicase Inhibitor HRO761 Targets MSI-High and dMMR Tumors
去年
Dostarlimab Shows Promise in Eliminating Need for Surgery Across Multiple dMMR Cancer Types
去年
NGS Demonstrates High Concordance with IHC for MSI Assessment in Solid Tumors
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Promise in dMMR Subgroup
去年
Accent Therapeutics' ATX-559, a First-in-Class DHX9 Inhibitor, Receives FDA IND Clearance for Solid Tumor Trial
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Benefit in dMMR Subgroup
去年
Spatial Analysis Reveals Tumor-Stroma Boundary Organization Impacts Immunotherapy Response in Colorectal Cancer
2年前
Pembrolizumab Plus Chemotherapy Demonstrates DFS Benefit in dMMR Endometrial Cancer Subgroup
去年
Roche's Tecentriq Cuts Colon Cancer Recurrence by 50% in Patients with DNA Repair Defects
去年
Agilent's MMR IHC Panel PharmDx Receives FDA Approval as Companion Diagnostic for Colorectal Cancer Immunotherapy
第 1 页,共 547 页
上一页
下一页